Y-Intercept (HK)’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Y-Intercept (HK)’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,264	Closed	-$811K	–	2041
2024 Q1	$811K	Buy	44,264 +33,347	+305%	+$529K	0.06%	475
2023 Q4	$134K	Buy	+10,917	New	+$102K	0.01%	1065
2023 Q1	–	Sell	-5,209	Closed	-$275K	–	1625
2022 Q4	$275K	Buy	+5,209	New	+$254K	0.04%	696

Other funds holding SILK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Y-Intercept (HK)'s SILK Position: Q2 2024 in Review

Y-Intercept (HK) sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 44,264 shares — an estimated $811K sold.

Y-Intercept (HK) first reported a position in SILK in Q4 2022 and held it in 3 quarters. The position peaked at $811K in Q1 2024. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

Y-Intercept (HK) reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Y-Intercept (HK) sold 44,264 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $811K.
Y-Intercept (HK) first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Y-Intercept (HK)'s Silk Road Medical, Inc. Common Stock position peaked at $811K in Q1 2024.
172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.